• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化脓性汗腺炎:一种毛囊性先天性免疫屏障功能障碍性疾病?

Hidradenitis suppurativa: A folliculotropic disease of innate immune barrier dysfunction?

作者信息

Johnston Daniel G W, Kirby Brian, Tobin Desmond J

机构信息

The Charles Institute of Dermatology, School of Medicine, University College Dublin, Dublin 4, Ireland.

Charles Department of Dermatology, St Vincent's University Hospital, Dublin, Ireland.

出版信息

Exp Dermatol. 2021 Oct;30(10):1554-1568. doi: 10.1111/exd.14451. Epub 2021 Aug 27.

DOI:10.1111/exd.14451
PMID:34418166
Abstract

The innate immune system of human skin consists of a multi-layered barrier consisting of cells and soluble effector molecules charged with maintaining homeostasis and responding to insults and infections. It has become increasingly clear that these barrier layers become compromised in skin diseases, especially in disorders of an (auto)inflammatory nature. In the case of hidradenitis suppurativa, great strides have been made in recent years in characterizing the underlying breakdown in homeostatic innate immunity, including an increasing understanding of the central role of the hair follicle in this process. This breakdown appears to occur at multiple levels: the pilosebaceous unit, associated epithelium, the cutaneous microbiome, alteration of immune cell function and local molecular events such as complement activation. This review seeks to summarize, contextualize and analyse critically our current understanding of how these innate immune barriers become dysregulated in the early stage(s) of hidradenitis suppurativa, and to speculate on where potential hidradenitis suppurativa research could be most fruitful.

摘要

人类皮肤的固有免疫系统由多层屏障组成,该屏障由细胞和可溶性效应分子构成,负责维持体内平衡并应对损伤和感染。越来越清楚的是,这些屏障层在皮肤疾病中会受到损害,尤其是在具有(自身)炎症性质的疾病中。就化脓性汗腺炎而言,近年来在确定稳态固有免疫的潜在破坏方面取得了长足进展,包括对毛囊在这一过程中的核心作用有了越来越深入的了解。这种破坏似乎发生在多个层面:皮脂腺单位、相关上皮组织、皮肤微生物群、免疫细胞功能的改变以及局部分子事件,如补体激活。本综述旨在总结、梳理并批判性地分析我们目前对化脓性汗腺炎早期这些固有免疫屏障如何失调的理解,并推测化脓性汗腺炎潜在研究最可能取得丰硕成果的方向。

相似文献

1
Hidradenitis suppurativa: A folliculotropic disease of innate immune barrier dysfunction?化脓性汗腺炎:一种毛囊性先天性免疫屏障功能障碍性疾病?
Exp Dermatol. 2021 Oct;30(10):1554-1568. doi: 10.1111/exd.14451. Epub 2021 Aug 27.
2
Yin and Yang: A disrupted skin microbiome and an aberrant host immune response in hidradenitis suppurativa.阴阳:化脓性汗腺炎中皮肤微生物群紊乱与宿主免疫反应异常
Exp Dermatol. 2021 Oct;30(10):1453-1470. doi: 10.1111/exd.14398. Epub 2021 Jun 2.
3
Innate immunity and microbial dysbiosis in hidradenitis suppurativa - vicious cycle of chronic inflammation.先天性免疫和微生物失调与化脓性汗腺炎-慢性炎症的恶性循环。
Front Immunol. 2022 Jul 28;13:960488. doi: 10.3389/fimmu.2022.960488. eCollection 2022.
4
Role of the Complement Pathway in Inflammatory Skin Diseases: A Focus on Hidradenitis Suppurativa.补体途径在炎症性皮肤病中的作用:以化脓性汗腺炎为例。
J Invest Dermatol. 2020 Mar;140(3):531-536.e1. doi: 10.1016/j.jid.2019.09.009. Epub 2019 Dec 20.
5
Update on pathogenesis of hidradenitis suppurativa.化脓性汗腺炎发病机制的最新进展。
G Ital Dermatol Venereol. 2018 Jun;153(3 Suppl 2):3-7. doi: 10.23736/S0392-0488.17.05798-4.
6
Pathogenesis: common pathways between hidradenitis suppurativa and Crohn disease.发病机制:化脓性汗腺炎与克罗恩病之间的共同途径。
Actas Dermosifiliogr. 2016 Sep;107 Suppl 2:13-20. doi: 10.1016/S0001-7310(17)30004-2.
7
Hidradenitis suppurativa: a review of cause and treatment.化脓性汗腺炎:病因与治疗的综述。
Curr Opin Infect Dis. 2011 Apr;24(2):118-23. doi: 10.1097/QCO.0b013e3283428d07.
8
Tumour necrosis factor-alpha and matrix metalloproteinase-2 are expressed strongly in hidradenitis suppurativa.肿瘤坏死因子-α和基质金属蛋白酶-2在化脓性汗腺炎中表达强烈。
Acta Derm Venereol. 2013 May;93(3):301-4. doi: 10.2340/00015555-1492.
9
Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa.先天免疫和上皮细胞分化的改变是化脓性汗腺炎的分子基础。
J Eur Acad Dermatol Venereol. 2020 Apr;34(4):846-861. doi: 10.1111/jdv.16147. Epub 2020 Jan 30.
10
Targeting dysbiosis in psoriasis, atopic dermatitis, and hidradenitis suppurativa: the gut-skin axis and microbiome-directed therapy.靶向银屑病、特应性皮炎和化脓性汗腺炎中的菌群失调:肠-皮肤轴和微生物组导向治疗。
Clin Dermatol. 2023 Sep-Oct;41(5):640-649. doi: 10.1016/j.clindermatol.2023.09.019. Epub 2023 Oct 9.

引用本文的文献

1
Transcriptomic Signatures and Molecular Pathways in Hidradenitis Suppurativa-A Narrative Review.化脓性汗腺炎的转录组特征和分子途径——一篇叙述性综述
Int J Mol Sci. 2025 Aug 9;26(16):7704. doi: 10.3390/ijms26167704.
2
Trained Immunity and Its Potential Implications in the Etiopathogenesis of Hidradenitis Suppurativa: A New Paradigm in Chronic Inflammation?训练有素的免疫及其在化脓性汗腺炎病因发病机制中的潜在影响:慢性炎症的新范式?
Exp Dermatol. 2025 Aug;34(8):e70160. doi: 10.1111/exd.70160.
3
Causal relationship between skin microbiota and Hidradenitis suppurativa: a two-sample Mendelian randomization study.
皮肤微生物群与化脓性汗腺炎之间的因果关系:一项两样本孟德尔随机化研究
Arch Dermatol Res. 2025 Jan 13;317(1):238. doi: 10.1007/s00403-024-03787-3.
4
A Hidradenitis Suppurativa molecular disease signature derived from patient samples by high-throughput RNA sequencing and re-analysis of previously reported transcriptomic data sets.基于高通量 RNA 测序和对先前报道的转录组数据集的重新分析,从患者样本中提取的化脓性汗腺炎分子疾病特征。
PLoS One. 2023 Apr 6;18(4):e0284047. doi: 10.1371/journal.pone.0284047. eCollection 2023.
5
Overexpression of hypoxia-inducible factor-1α in hidradenitis suppurativa: the link between deviated immunity and metabolism.在化脓性汗腺炎中缺氧诱导因子-1α 的过表达:偏离的免疫与代谢之间的联系。
Arch Dermatol Res. 2023 Sep;315(7):2107-2118. doi: 10.1007/s00403-023-02594-6. Epub 2023 Mar 24.
6
Cell-free DNA is elevated in the serum of patients with hidradenitis suppurativa.化脓性汗腺炎患者血清中的游离DNA水平升高。
J Dermatol. 2023 Feb;50(2):271-273. doi: 10.1111/1346-8138.16676. Epub 2022 Dec 14.
7
Response to Martora et al's "Hidradenitis suppurativa flares following COVID-19 vaccination: a case series".对马尔托拉等人的《新冠病毒疫苗接种后化脓性汗腺炎发作:病例系列》的回应
JAAD Case Rep. 2022 Jul;25:13-14. doi: 10.1016/j.jdcr.2022.05.005. Epub 2022 May 10.